Christophe Van Huffel
Millennium Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christophe Van Huffel.
Annals of the New York Academy of Sciences | 1994
Bruce Beutler; Christophe Van Huffel
Hormones undergo pronounced structural change in the course of evolution, yet each one retains its affinity for a specific receptor. Receptors also undergo change over time. How is it that structural changes in one member of a receptornigand pair are “anticipated” by changes in the structure of its partner? On an evolutionary scale, such changes may be very rapid. Hence, murine gamma interferon has but little affinity for the human gamma interferon receptor, and vice versu, although within each of these two species, the affinity between gamma interferon and its receptor has remained strong. Moreover, present-day functions of a given hormone may bear little semblance to the functions that its molecular ancestor served one billion years ago. How, then, were changes in function tolerated? The molecular cloning of several dozen proteins, somewhat arbitrarily lumped together as “interleukins,” “colony-stimulating factors,” “chemokines,” and “tumor necrosis factors” has permitted very detailed consideration of this issue. Not only the structure, but also the function of phylogenetically related molecules may be applied toward construction of a hypothesis as to how coevolution of hormones and their receptors may occur. Inasmuch as understanding of function is usually best advanced by analysis of the failure of function, much effort has been spent on the identification of defects of cytokine production or activity. Certain diseases can now be attributed to discrete mutations of genes encoding cytokines’” or their receptor^?^ and when nature has not provided such mutations, attempts have been made to introduce them artificially.6” As a result, the essential actions of cytokines have become somewhat clearer than they were a few years ago. In the present review, we offer a detailed description of the TNF ligand and receptor families and speculate as to their evolutionary and functional origins.
Science | 1998
Alexander Poltorak; Xiaolong He; Irina Smirnova; Mu Ya Liu; Christophe Van Huffel; Xin Du; Dale Birdwell; Erica Alejos; Maria Silva; Chris Galanos; Marina A. Freudenberg; Paola Ricciardi-Castagnoli; Betsy Layton; Bruce Beutler
Blood Cells Molecules and Diseases | 1998
Alexander Poltorak; Irina Smirnova; Xiaolong He; Mu Ya Liu; Christophe Van Huffel; Dale Birdwell; Erica Alejos; Maria Silva; Xin Du; Patricia A. Thompson; Edward K. L. Chan; Jessica Ledesma; Bruce A. Roe; Sandra W. Clifton; Stefanie N. Vogel; Bruce Beutler
Science | 1998
Alexander Poltorak; Xiaolong He; Irina Smirnova; Mu-Ya Liu; Christophe Van Huffel; Xin Du; Dale Birdwell; Erica Alejos; Maria Silva; Chris Galanos; Marina A. Freudenberg; Paola Ricciardi-Castagnoli; Elizabeth Layton; Bruce Beutler
Cancer Genetics and Cytogenetics | 1999
Mohini Lutchman; Svetlana Pack; Anthony C. Kim; Anser C. Azim; Michael R. Emmert-Buck; Christophe Van Huffel; Zhengping Zhuang; Athar H. Chishti
Archive | 1999
Andrew W. Shyjan; Christophe Van Huffel
Genomics | 1997
Anthony C. Kim; Luanne L. Peters; Joan H. M. Knoll; Christophe Van Huffel; Steven L. Ciciotte; Patrick W. Kleyn; Athar H. Chishti
Archive | 2001
Frederick P. Roth; Christophe Van Huffel; James V. White; Andrew W. Shyjan
Genomics | 1998
Anthony C. Kim; Christophe Van Huffel; Mohini Lutchman; Athar H. Chishti
Archive | 1999
Shengfang Jin; Andrew W. Shyjan; Christophe Van Huffel